Clinical Trial Update: Upfront Treatment With Chemotherapy and Bevacizumab in Advanced Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating upfront chemotherapy with bevacizumab in advanced ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Chemotherapy (chemotherapy)

Snippet

Sponsor: Nada Hassan Salah | Conditions: Advanced Ovarian Cancer | Phase 2 | Status: UNKNOWN